• Certara Scientists to Highlight Model-informed Drug Development, PBPK, MBMA and Quantitative Systems Pharmacology Progress at PAGE 2019

    Jun 10, 2019, 10:20 by Michael Croft
    PRINCETON, NJ - Jun 10, 2019 - Certara® the global leader in model-informed drug development, regulatory science, real-world evidence and market access services, today announced that its scientists will participate in 28 sessions at the Population Approach Group in Europe (PAGE) 2019 Annual Meeting
    Full story
  • CRF Bracket Relaunches As Signant Health

    Jun 10, 2019, 09:10 by Michael Croft

    Clinical Research News | CRF Bracket announced a new name and brand today. The company will now be known as Signant Health, a name more indicative of the kind of business the company is trying to build.

    Full story
  • Rho Experts Discuss the Importance of Early Patient Involvement in Clinical Trial Design in Free Webinar

    Jun 5, 2019, 17:07 by Michael Croft
    DURHAM, NC - Jun 6, 2019 - Rho Experts Discuss the Importance of Early Patient Involvement inClinical Trial Design in Free Webinar WHAT:                 Patient-centricity gets a lot of buzz as an essential aspect in research, drug development and disease management
    Full story
  • Why Pfizer Didn't Report Its Rheumatoid Arthritis Medication Might Prevent Alzheimer's

    Jun 5, 2019, 11:15 by Michael Croft

    The Washington Post | A team of researchers inside Pfizer found the company's blockbuster rheumatoid arthritis therapy Enbrel, a powerful anti-inflammatory drug, appeared to reduce the risk of Alzheimer's disease by 64%. However, Pfizer opted against further investigation and chose not to make the data public, the company confirmed.

    Full story
  • Finding The Sweet Spot: Why Industry, Nonprofits Should (Or Can) Collaborate On Master Protocols

    Jun 4, 2019, 11:30 by Michael Croft

    Clinical Research News Contributed Commentary | Healthcare research often gets caught up in conflicting priorities among drug makers, research institutions, patient organizations, and regulators—and nowhere is this more prevalent than in clinical research.

    Full story
  • BioIVT HEPATOPAC® Meeting to Highlight Advances in Drug Discovery Research

    Jun 3, 2019, 10:44 by Michael Croft
    WESTBURY, NY - Jun 3, 2019 - BioIVT, a leading provider of research models and services for drug and diagnostic development, today announced that it will be hosting a HEPATOPAC Meeting at the AC Hotel by Marriott, San Francisco Airport/Oyster Point Waterfront on June 7
    Full story
  • MR Solutions’ multi-modality, cryogen free technology is recognised as the norm at the ISMRM meeting in Montreal

    May 30, 2019, 10:45 by Michael Croft
    GUILDFORD, UNITED KINGDOM - May 30, 2019 - PRESS RELEASE24.05.19 MR Solutions’ high field simultaneous PET-MR systems and large bore, 7T cryogen free MRI technology were seen to be game-changers by leading molecular imaging researchers at the 27th Annual Meeting of the International Society for Magnetic Resonance in Medicine (ISMRM)[i], in Montreal last week
    Full story
  • CRF Bracket’s World-Class Clinical Research Technology wins European PIN Award for Second Year in Row

    May 30, 2019, 10:38 by Michael Croft
    PHILADELPHIA, PA - May 30, 2019 - CRF Bracket’s Romania office celebrates yet another European award after being named IT Company of the Year in Romania’s Regional IT & Outsourcing Industry Awards (also known as the PIN Awards)
    Full story
  • Caris, ICON, Parexel, And More: News From May 2019

    May 30, 2019, 09:30 by Michael Croft

    Clinical Research News | May was full of exciting news in the clinical trial and healthcare community, including partnerships, products, and promotions from Caris, ICON, Parexel, and more.

    Full story
  • BioIVT Named Service Provider for Promega Immunotherapy Bioassays

    May 29, 2019, 09:39 by Michael Croft
    WESTBURY, NY - May 29, 2019 - BioIVT, a leading provider of research models and services for drug and diagnostic development, today announced that it will now offer Promega Immune Checkpoint and antibody-dependent cell-mediated cytotoxicity (ADCC) Reporter Bioassays to support immunology and immuno-oncology research
    Full story
  • Right Technology And Touch Needed In Early Clinical Development

    May 29, 2019, 07:50 by Michael Croft

    Clinical Research News | In many respects, High Point Clinical Trials Center (HPCTC) is not your run-of-the-mill phase I study site.

    Full story
  • MakroCare is recognized as “The Outstanding Consulting Firms 2019”

    May 29, 2019, 03:11 by Michael Croft
    PRINCETON, NJ, US - May 29, 2019 - MakroCare has recognized as an outstanding consulting firm by Insights Success in the Outstanding Consulting Firms 2019 magazine
    Full story
  • Certara Introduces Integral, its Next-generation Data Repository

    May 28, 2019, 08:16 by Michael Croft
    PRINCETON, NJ - May 28, 2019 - Certara® the global leader in model-informed drug development, regulatory science, real-world evidence and market access services, today announced the introduction of Certara Integral™, its next-generation data repository for collecting, managing, and storing multiple types of data sets for analysis, sharing and reporting of clinical pharmacology, pharmacometrics and other relevant clinical data
    Full story
  • Reprieve Cardiovascular Announces Late-Breaking Acute Heart Failure Clinical Trial Data

    May 28, 2019, 05:14 by Michael Croft
    MILFORD, MA - May 25, 2019 -
    • TARGET-1 and TARGET-2 trials: safe decongestion using first fully automated fluid management system 
    • Significant increase in diuresis, net negative fluid balance, improvement of kidney function and improvement in clinical symptoms
    • Significant drop in CVP while systolic BP remained stable
    Reprieve Cardiovascular™, a pioneering medical device company focused on improving outcomes for patients suffering from Acute Decompensated Heart Failure (ADHF), today announced the results of two non-randomized, prospective clinical trials in patients hospitalized with Acute Heart Failure (AHF)
    Full story
  • RX In Chains: Transform Drug Adherence, Combat Counterfeits With Blockchain

    May 24, 2019, 08:20 by Michael Croft

    Clinical Research News Contributed Commentary | Up to 1 million deaths are attributed to counterfeit prescriptions annually. Blockchain presents the opportunity to mitigate the counterfeit drug trade, yet the technology has implications beyond the problem.

    Full story
  • Building A Research-Grade EMR From The Ground Up

    May 23, 2019, 08:40 by Michael Croft

    Clinical Research News | Electronic medical record systems contain a wealth of longitudinal real-world data but, as researchers are aware, were never purposefully built for running trials or finding patients to populate them. Canadian-based site network LMC Manna Research is working against that, finding a creative way to support a community-based model of care.

    Full story
  • Verily, Pharma Join Together To Develop Clinical Research Programs With Project Baseline

    May 21, 2019, 13:00 by Michael Croft

    Clinical Research News Brief | Today Verily, an Alphabet company, announced strategic alliances with Novartis, Otsuka, Pfizer, and Sanofi to develop digitally innovative, patient-centered clinical research programs using Project Baseline’s evidence generation platform and tools.

    Full story
  • Lazarex Foundation Works To Achieve Minority Equity In Cancer Clinical Trials

    May 21, 2019, 09:15 by Michael Croft

    Clinical Research News | The Lazarex Cancer Foundation is working to sustainably achieve minority equity and increased enrollment in cancer clinical trials nationwide by eliminating financial barriers, increasing community outreach, collaborating with comprehensive cancer centers, and attaining bipartisan Congressional action.

    Full story
  • WCG to Lead Educational Session on Implementing the Revised Common Rule at AAHRPP Annual Conference

    May 20, 2019, 11:33 by Michael Croft
    PRINCETON, NJ - May 20, 2019 - The WIRB-Copernicus Group® (WCG™) announced today that David Borasky, MPH, CIP, its vice president, IRB Compliance will be leading an educational session on the revised Common Rule at the Association for the Accreditation of Human Research Protection Programs, Inc
    Full story
  • Shimmer President to Discuss the Optimal Use of Wearable Sensors in Clinical Trials at Body Sensor Networks 2019 Workshop

    May 18, 2019, 22:33 by Michael Croft
    CAMBRIDGE, MA - May 18, 2019 - Shimmer, a global leader in wearable technology for research applications, today announced that Geoff Gill, president of Shimmer Americas, will be presenting at the Body Sensor Networks (BSN) ’19 pre-conference workshop entitled, “Using mHealth Technology to Enable the Clinical Trial of the Future
    Full story
  • «
  • 191
  • 192
  • 193
  • 194
  • 195 (current)
  • 196
  • 197
  • 198
  • 199
  • 200
  • »